Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-9 of 9
Keywords: UFT
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Effect of Cyclic Cisplatin and Etoposide Therapy with Continuous UFT Administration on the Recurrence of Endometrial Cancer in Nude Mice
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1993) 50 (4): 209–213.
Published Online: 26 June 2009
...Mitsuaki Suzuki; Ichiro Aida; Isao Sekiguchi; Taro Tamada; Sumiaki Tsuru Effects of cisplatin and etoposide chemotherapy and/or continuous administration of oral anticancer agent UFT following the initial chemotherapy with cisplatin and etoposide on the tumor recurrence rate were studied...
Journal Articles
Low Uracil Concentration in the Liver might be Responsible for the Decreased Antineoplastic Activity of Fluoropyrimidines in Mice with CCl 4 -Induced Chronic Liver Dysfunction
Available to PurchaseSubject Area:
Oncology
Michihiko Tsubono, Yoshinori Nio, Shiro Imai, Takahiro Shiraishi, Hideki Morimoto, Chen-Chiu Tseng, Kazuya Kawabata, Manabu Fukumoto, Takayoshi Tobe
Journal:
Oncology
Oncology (1991) 48 (3): 246–252.
Published Online: 26 June 2009
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Fluoropyrimidine CCl 4 -induced liver dysfunction 5-Fluorouracil Tegafur [l-(2-tetrahydrofuryl)-5-fluorouracil] UFT...
Journal Articles
Phase I/II Study of Twenty-Four-Hour Infusion of Irinotecan in Combination with Oral UFT plus Leucovorin for Metastatic Colorectal Cancer
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2009) 76 (5): 338–341.
Published Online: 23 March 2009
.../II trial was performed to evaluate the efficacy and safety of continuous infusion of irinotecan combined with UFT plus leucovorin (LV) for metastatic colorectal cancer. Methods: Escalating doses of irinotecan (90–110 mg/m 2 ) were administered by 24-hour infusion on day 1. UFT 300 mg/m 2 /day and LV...
Journal Articles
The Role of UFT in Metastatic Colorectal Cancer
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2009) 76 (5): 301–310.
Published Online: 20 March 2009
...Jaafar Bennouna; Mark Saunders; Jean-Yves Douillard 5-Fluorouracil (5-FU) has been the most widely used chemotherapeutic agent for metastatic colorectal cancer (mCRC) and 5-FU combination therapy improves efficacy compared with monotherapy. The oral fluoropyrimidine UFT (tegafur-uracil...
Journal Articles
UFT as Maintenance Therapy in Patients with Advanced Colorectal Cancer Responsive to the FOLFOX4 Regimen
Available to PurchaseSubject Area:
Oncology
R. Scalamogna, S. Brugnatelli, C. Tinelli, P. Sagrada, E. Gattoni, M.C. Tronconi, A. Riccardi, G. Luchena, G.R. Corazza
Journal:
Oncology
Oncology (2008) 72 (5-6): 267–273.
Published Online: 11 January 2008
... in about 50% of patients during the 6-month FOLFOX4 regimen, and the frequent need for hospitalization, alternative regimens may be required. We aimed to determine whether a ‘maintenance’ therapy with oral UFT (uracil-tegafur) in patients responding to FOLFOX4 is able to maintain the response and improve...
Journal Articles
The Role of New Agents in the Treatment of Colorectal Cancer
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2004) 66 (1): 1–17.
Published Online: 19 March 2004
...Gunnar Folprecht; Claus-Henning Köhne New drugs improved efficacy or convenience of treatment in metastatic colorectal cancer. The oral fluoropyrimidines capecitabine and UFT are less toxic but equally efficacious relative to intravenous bolus 5-fluorouracil (5-FU)/folinic acid (FA). These agents...
Journal Articles
Meta-Analysis of Five Studies on Tegafur plus Uracil (UFT) as Post-Operative Adjuvant Chemotherapy for Breast Cancer
Available to PurchaseSubject Area:
Oncology
Fujio Kasumi, Masataka Yoshimoto, Junichi Uchino, Rikiya Abe, Yasuo Nomura, Keizo Sugimachi, Hiroaki Nakazato, Osahiko Abe
Journal:
Oncology
Oncology (2003) 64 (2): 146–153.
Published Online: 03 February 2003
...Fujio Kasumi; Masataka Yoshimoto; Junichi Uchino; Rikiya Abe; Yasuo Nomura; Keizo Sugimachi; Hiroaki Nakazato; Osahiko Abe Meta-analysis of 5 studies on postoperative breast cancer cases (2 studies on surgery alone vs. tegafur plus uracil (UFT) and 3 studies on tamoxifen (TAM) alone vs. TAM + UFT...
Journal Articles
Oral Combination of Cyclophosphamide, Uracil plus Tegafur and Estramustine for Hormone-Refractory Prostate Cancer
Available to PurchaseSubject Area:
Oncology
K. Nishimura, N. Nonomura, Y. Ono, M. Nozawa, T. Fukui, Y. Harada, T. Imazu, N. Takaha, H. Sugao, T. Miki, A. Okuyama
Journal:
Oncology
Oncology (2000) 60 (1): 49–54.
Published Online: 28 December 2000
...K. Nishimura; N. Nonomura; Y. Ono; M. Nozawa; T. Fukui; Y. Harada; T. Imazu; N. Takaha; H. Sugao; T. Miki; A. Okuyama Objective: To evaluate the clinical usefulness of an oral combination of cyclophosphamide, uracil plus tegafur (UFT) and estramustine in the treatment of patients with hormone...
Journal Articles
Fluoropyrimidines: A Critical Evaluation
Available to PurchaseSubject Area:
Oncology
Rogelio A. Brito, Diana Medgyesy, Thomas H. Zukowski, Melanie E Royce, Farhad Ravandi-Kashani, Paulo M. Hoff, Richard Pazdur
Journal:
Oncology
Oncology (1999) 57 (Suppl. 1): 2–8.
Published Online: 21 July 1999
... Colon cancer Fluoropyrimidines 5-FU UFT S-1 Xeloda ® (capecitabine) Emitefur Eniluracil Oral chemotherapy 5-FU has been studied in several different dosing regimens, including a daily bolus schedule for five consecutive days, weekly bolus schedules and continuous infusions extending...